Get started
Author

G.O.N. Oosterhof

Observed names: G O Oosterhof, G Oosterhof, G. O. N. OOSTERHOF, G. O. N. Oosterhof, G.O. N. Oosterhof, G.O.N. OOSTERHOF, Gosse O.N. Oosterhof
Observed institutions: Radboud University Nijmegen, Maastricht University Medical Centre, Radboud University Medical Center, Canisius-Wilhelmina Ziekenhuis, De Wever-Ziekenhuis, Martin Luther University Halle-Wittenberg
OpenAlex ID: A5113645301
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
1994 · R Umbas, W B Isaacs, et al. · PubMed · 530
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)
2004 · H.J. Schmoll, R. Souchon, et al. · Annals of Oncology · 507
PDF
Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.
1996 · G J Jager, J O Barentsz, et al. · American Journal of Roentgenology · 255
Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology.
1996 · G J Jager, E T Ruijter, et al. · American Journal of Roentgenology · 248
Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
1997 · G J Jager, E T Ruijter, et al. · Radiology · 230
PDF
Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250.
1997 · M G Steffens, O C Boerman, et al. · Journal of Clinical Oncology · 157
Strontium89 Chloride versus Palliative Local Field Radiotherapy in Patients with Hormonal Escaped Prostate Cancer: A Phase III Study of the European Organisation for Research and Treatment of Cancer Genitourinary Group
2003 · G.O.N. Oosterhof, J.T. Roberts, et al. · European Urology · 136
In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue.
1997 · A Heerschap, G J Jager, et al. · PubMed · 131
PDF
Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging.
1998 · J O Barentsz, O Berger-Hartog, et al. · Radiology · 104
Influence of High-Intensity Focused Ultrasound on the Development of Metastases
1997 · G.O.N. Oosterhof, E.B. Cornel, et al. · European Urology · 95
Characterization of Human Prostate Cancer, Benign Prostatic Hyperplasia and Normal Prostate by in vitro1H and31P Magnetic Resonance Spectroscopy
1993 · E.B. Cornel, G.A.H.J. Smits, et al. · The Journal of Urology · 94
EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma
1995 · on behalf of the EORTC Genitourinary Group, PHM De Mulder, et al. · British Journal of Cancer · 68
Staging urinary bladder cancer: value of T1-weighted three-dimensional magnetization prepared-rapid gradient-echo and two-dimensional spin-echo sequences.
1995 · J O Barentsz, G Jager, et al. · American Journal of Roentgenology · 65
PDF
Prostate‐specific antigen density: correlation with histological diagnosis of prostate cancer, benign prostatic hyperplasia and prostatitis
1995 · M.P. VAN IERSEL, W.P.J. WITJES, et al. · British Journal of Urology · 64
Prognostic factors in pT a ‐pT 1 superficial bladder tumours treated with intravesical instillations
1994 · P. F. A. MULDERS, A. P. M. v. d. MEYDEN, et al. · British Journal of Urology · 56
Urological Complications in Renal Transplantation
1997 · J. Cimic, E.J.H. Meuleman, et al. · European Urology · 48
Prognostic Factors in Superficial Bladder Cancer
1992 · J.A. Witjes, L.A.L.M. Kiemeney, et al. · European Urology · 48
The in vitro effect of electromagnetically generated shock waves (Lithostar) on the Dunning R3327 PAT-2 rat prostatic cancer cell-line
1989 · G. O. N. Oosterhof, G. A. H. J. Smits, et al. · Urological Research · 48
Effect of a Nutritional Supplement Containing Vitamin E, Selenium, Vitamin C and Coenzyme Q10 on Serum PSA in Patients with Hormonally Untreated Carcinoma of the Prostate: A Randomised Placebo-Controlled Study
2004 · K.M.J.L.F. Hoenjet, P.C. Dagnelie, et al. · European Urology · 45
Intratumoral distribution of two consecutive injections of chimeric antibody G250 in primary renal cell carcinoma: implications for fractionated dose radioimmunotherapy.
1999 · M G Steffens, O C Boerman, et al. · PubMed · 45
Treatment of Stones in Caliceal Diverticula: Extracorporeal Shock Wave Lithotripsy versus Percutaneous Nephrolitholapaxy
1992 · A. J. M. HENDRIKX, A. F. BIERKENS, et al. · British Journal of Urology · 42
Toxicity and Results of MVAC (Methotrexate, Vinblastine, Adriamycin and Cisplatin) Chemotherapy in Advanced Urothelial Carcinoma
1997 · J.A. Witjes, M. Wullink, et al. · European Urology · 39
Anterograde Percutaneous Treatment of Ureterointestinal Strictures following
1996 · A.F. Bierkens, G.O.N. Oosterhof, et al. · European Urology · 38
The Importance of Prognostic Factors in the Individual Treatment of Patients with Disseminated Germ Cell Tumours
1990 · P. F. A. MULDERS, G. O. N. OOSTERHOF, et al. · British Journal of Urology · 38
Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
1996 · W P Witjes, J A Witjes, et al. · PubMed · 37
Works count: 72
Citation count: 3,587
H-index: 28
I10-index: 41
Year
Topic
Type